Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Access and The Dow Chemical Company enter into collaboration

Aug. 4, 1997

Stanford scientists report breakthrough in polyketide research

Aug. 4, 1997

Xoma issued further U.S. patents based on BPI platform

Aug. 1, 1997

Cel-Sci allowed patent for immune system technology

Aug. 1, 1997

Vyrex awarded U.S. patent for CD-Tagging

Aug. 1, 1997

Jenner licenses emulsion formulation from Walter Reed

July 29, 1997

RPR prepares novel transfection agents

July 29, 1997

Abgenix and Neugenesis collaborate on monoclonal antibody production

July 28, 1997

Oncogene Science and Hoechst Marion Roussel extend collaboration

July 28, 1997

Oxford BioMedica receives grant for the development of anticancer technology

July 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...